Analyst Ratings for Neurogene (NGNE)
NGNE Rating Summary
NGNE Price Target Summary
- Highest: $180.00 (Canaccord)
- Lowest: $46.00 (Stifel)
- Average: $77.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$77.50 (+166.3%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Avg. $ Target:
$77.50 (+166.3%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/3/2026 | Rodman & Renshaw | Seema Sheoran | New Coverage | Buy (N/A) |
70.00 (N/A) |
26.14 (29.10) |
11.32% | Details |
| 1/26/2026 | LifeSci Capital | Patrick Dolezal | New Coverage | Outperform (N/A) |
50.00 (N/A) |
18.31 (29.10) |
58.93% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
